HCPCS Code C9014

Injection, cerliponase alfa, 1 mg
Code effective Jan 01, 2019

HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System

C9014 is a valid 2026 HCPCS code meaning Injection, cerliponase alfa, 1 mg or (Injection, cerliponase alfa) for short. HCPCS C9014 has been effective since 01/01/2019 and applies to Other medical items or services.

HCPCS Code Details - C9014

HCPCS Level II Code
Section C - Temporary Codes for Use with Outpatient Prospective Payment System
HCPCS Code C9014
Description

Long description:
Injection, cerliponase alfa, 1 mg

Short description:
Injection, cerliponase alfa

HCPCS Pricing indicator 53 - Statute
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Statute number 1833(t)
Coverage code D - Special coverage instructions apply
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 9 - Other medical items or services
Effective date Effective Jan 01, 2019
Date added Added Jan 01, 2018
Termination date Dec 31, 2018

See also

  • HCPCS C8957 · Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump

  • HCPCS J0567 · Injection, cerliponase alfa, 1 mg

  • HCPCS C9015 · Injection, c-1 esterase inhibitor (human), haegarda, 10 units

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.